Skip to content

Dismembered Pyeloplasty With and Without After Coming Stent

Dismembered Pyeloplasty With and Without After Coming Stent in Neonatal Ureteropelvic Junction Obstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02138877
Enrollment
30
Registered
2014-05-15
Start date
2014-01-31
Completion date
2015-06-30
Last updated
2016-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Hydronephrosis, Obstructive Uropathy, Pelviureteric Junction Obstruction, Pyeloplasty, Urinary Stent

Keywords

Pelviureteric junction obstruction, pyeloplasty, Neonate affected by hydronephrosis, obstructive uropathy, urinary stent

Brief summary

to compare outcome of pyeloplasty in pediatric population less than 6 months in age using an after coming stent versus stentless pyeloplasty.

Detailed description

A prospective randomized control study including patients divided into two groups,all patient undergoes dismembered pyeloplasty First group will be with an after coming stent ,Second group will be stentless to compare outcome of pyeloplasty in pediatric population less than 6 months in age

Interventions

PROCEDUREAfter coming stent after dismembered pyeloplasty

Dismembered pyeloplasty through lumbar incision. The patients who are randomized to the after coming stent arm, an after coming stent is inserted. Distal part of it is positioned in the mid ureter. The proximal end is passed through the renal parenchyma (usually the lower kidney calyx) to be exteriorized through stab wound and fixed to the skin. The size of external stent is 4-5 F.

PROCEDUREStentless dismembered pyeloplasty

Dismembered pyeloplasty through lumbar incision. No stents are inserted

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Months
Healthy volunteers
No

Inclusion criteria

* Pelvi-ureteric junction obstruction (PUJO) * Asymptomatic obstruction with reduced function (less than 35-40%) * Asymptomatic obstruction with antero-posterior diameter exceed 40 mm * Asymptomatic obstruction with deterioration on conservative follow up. * Symptomatic PUJ obstruction, e.g. pain, renal mass, fever and stones.

Exclusion criteria

* Secondary Pelvi-ureteric junction obstruction * Solitary kidney * Gross pyuria * Ectopic kidney * Dilated ureter

Design outcomes

Primary

MeasureTime frameDescription
2ry intervention1 monthNeed for 2ry intervention in the form of insertion of ureteral stent
Fever1 monthPostoperative fever
Postoperative Hospital stay1 weekPostoperative Hospital stay
Leakage1 weekoccurrence of post operative leakage

Secondary

MeasureTime frameDescription
Assessment of kidney function after repair6 months\- Assessment of kidney function after repair using renogram and ultrasound
success6 monthsNeed for 2ry treatment of persistent pelviureteric junction obstruction

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026